New study aims to make complex pelvic cancer surgery safer
NCT ID NCT07395505
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at standardizing the surgical process for patients with advanced or recurrent rectal cancer that has spread to nearby organs. The procedure, called pelvic exenteration, removes the tumor along with affected structures. The goal is to improve teamwork among surgeons and track patient outcomes and quality of life. Twenty-four adults will take part over three years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- standardized surgical and care process
- What this could lead to
- If successful, this could establish best practices for complex pelvic surgeries, potentially improving recovery and reducing complications for future patients.
- What could go wrong
- This is a small, early-stage study with only 24 participants, so results may not apply to all patients. It does not test new treatments, so direct benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital, Linkou
Taoyuan, 33305, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.